Receptor Life Sciences
PrivateLast Round
Series A
Extension
Apr 7, 2022
Total Funding Raised
$38.7M
Company Overview
Receptor Life Sciences is a pharmaceutical company that develops innovative therapies for central nervous system disorders using FDA-approved drug delivery technologies for cannabinoid products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Receptor Life Sciences Comparables
Compare Receptor Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ANANDA Scientific | 79% | |
| UCB | 76% | |
| Synendos Therapeutics | 71% | |
Receptor Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Apr 7, 2022 | ||||
| Series A | Oct 29, 2018 |
Receptor Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Granite Point Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 7, 2022
$9.7M round led by Granite Point Capital
- Oct 29, 2018
$29M round completed.
Receptor Life Sciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Receptor Life Sciences's valuation, stock price, and market status.